Psma-1007 (18 f)

Prostalumin

3.7 GBQ / ML SolutionCanadaAuthorised

In other countries

The same active substances on other registers, the same brand first.

Radelumin 1300 MBQ/ML Solucion InyectableSpain · 1300 MBq/ml · solución inyectable · Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbhSame substance
Radelumin 2000 MBQ/ML Solucion InyectableSpain · 2000 MBq/ml · solución inyectable · Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbhSame substance
RadeluminItaly · Soluzione iniettabile · Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GMBHSame substance
Radelumin 1300 MBq/ml oplossing voor injectieNetherlands · Oplossing voor injectie · ABX advanced biochemical compounds, Biomedizinische Forschungsreagenzien GmbHSame substance
Radelumin 2000 MBq/ml oplossing voor injectieNetherlands · Oplossing voor injectie · ABX advanced biochemical compounds, Biomedizinische Forschungsreagenzien GmbHSame substance

Documents

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Psma-1007 (18 f)

Prostalumin

3.7 GBQ / ML SolutionCanadaAuthorised

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Psma-1007 (18 f)
Strength: 3.7 GBQ / ML
Dosage form: Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Authorised
Status in the register: Approved
Registration: DIN 02571757
Marketing authorisation holder: Centre for Probe Development and Commercialization
ATC code: V09IX17
Group: Various
Supply: SCHEDULE C